Delivery Order SPM20003D1666-DL44
Award Date 4/21/11
Potential Completion Date 4/22/11
Potential Value $48K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Perjeta 420 mg/14 ml vials with a ceiling value of $49,058.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical supply to Department of Defense healthcare facilities worldwide. The parent contract, awarded to DMS Pharmaceutical Group on November 13, 2025,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,259.08 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a $1,593.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 9, 2026, for diazepam injection under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-managed indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, with a ceiling value of $17,888 for Prolastin C 1,000 mg/20 ml vials, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency program authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations. Place of performance is...
- <p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on February 17, 2026, with a ceiling value of $159,177.64 for pharmaceutical products under its Pharmaceutical Prime Vendor program serving the PV Pharm Branch.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 18, 2026 and is priced on a firm fixed-price basis. No set-aside was used.</p>
- The Defense Logistics Agency issued a $17,688.64 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, with a ceiling value of $18,404.70 for Photrexa cross-linking kit 6ml, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a DLA-administered pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, for etonogestrel 68 mg with a ceiling value of $24,244.87 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a $7,594.65 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...